InnoCare Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	23,792	12,220	13,112	23,452	21,094	17,378
Market Cap Growth	106.16%	-6.80%	-44.09%	11.18%	21.38%	-
Enterprise Value	17,953	6,114	4,689	14,292	15,136	13,835
Last Close Price	11.83	6.12	6.89	13.64	15.30	13.48
PS Ratio	15.25	11.38	16.11	33.17	16.48	10727.94
PB Ratio	3.26	1.70	1.66	2.71	3.04	4.63
P/TBV Ratio	3.40	1.78	1.73	2.75	3.09	4.78
P/OCF Ratio	-	-	-	-	102.87	-
EV/Sales Ratio	11.51	5.69	5.76	20.22	11.82	8540.54
Debt / Equity Ratio	0.25	0.23	0.23	0.20	0.23	0.37
Net Debt / Equity Ratio	-0.80	-0.80	-0.92	-0.98	-0.87	-0.88
Net Debt / EBITDA Ratio	21.69	11.36	10.84	10.21	29.54	5.02
Net Debt / FCF Ratio	33.01	12.23	7.21	9.42	1821.44	6.60
Asset Turnover	0.15	0.10	0.07	0.07	0.18	0
Inventory Turnover	1.51	1.29	1.39	3.81	11.13	-
Quick Ratio	6.14	7.01	4.13	4.43	19.29	38.75
Current Ratio	6.54	7.45	4.21	4.48	19.49	39.18
Return on Equity (ROE)	-3.55%	-6.50%	-8.71%	-13.44%	-1.51%	-368.36%
Return on Assets (ROA)	-2.10%	-3.52%	-4.15%	-5.48%	-1.91%	-9.77%
Return on Capital Employed (ROCE)	-3.80%	-6.50%	-8.60%	-9.40%	-2.60%	-12.60%
Earnings Yield	-1.05%	-3.84%	-5.30%	-4.27%	-0.38%	-2.67%
FCF Yield	-0.75%	-3.86%	-7.73%	-3.82%	-0.02%	-2.89%
Buyback Yield / Dilution	5.87%	0.67%	-15.31%	-8.29%	-41.21%	-321.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.